Virtual Meeting to be held on August 21-22 hosted by B. Riley.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APRE:
- Aprea Therapeutics sees cash runway into 4Q25
- Aprea Therapeutics reports Q2 EPS (58c) vs. (87c) last year
- Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor, on Monday, June 24, 2024